EA200501368A1 - EMULSION COMPOSITION FOR ACTIVE SUBSTANCES (OPTIONS), METHOD OF OBTAINING IT (OPTIONS) AND CONTAINING IT MEANS (OPTIONS) - Google Patents

EMULSION COMPOSITION FOR ACTIVE SUBSTANCES (OPTIONS), METHOD OF OBTAINING IT (OPTIONS) AND CONTAINING IT MEANS (OPTIONS)

Info

Publication number
EA200501368A1
EA200501368A1 EA200501368A EA200501368A EA200501368A1 EA 200501368 A1 EA200501368 A1 EA 200501368A1 EA 200501368 A EA200501368 A EA 200501368A EA 200501368 A EA200501368 A EA 200501368A EA 200501368 A1 EA200501368 A1 EA 200501368A1
Authority
EA
Eurasian Patent Office
Prior art keywords
options
emulsion composition
obtaining
active substances
oil
Prior art date
Application number
EA200501368A
Other languages
Russian (ru)
Other versions
EA017434B1 (en
Inventor
Стен Бойе Йорсаль
Original Assignee
НОУВАСЕЛ ОСТРЕЙЛЮЭ ПиТиУай эЛТиДи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by НОУВАСЕЛ ОСТРЕЙЛЮЭ ПиТиУай эЛТиДи filed Critical НОУВАСЕЛ ОСТРЕЙЛЮЭ ПиТиУай эЛТиДи
Publication of EA200501368A1 publication Critical patent/EA200501368A1/en
Publication of EA017434B1 publication Critical patent/EA017434B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/068—Microemulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
    • C08G2650/58—Ethylene oxide or propylene oxide copolymers, e.g. pluronics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Эмульсионная композиция, содержащая водный компонент, неионный блок-сополимер и масло, в которой содержание сополимера составляет по крайней мере 10 вес.%.Международная заявка была опубликована вместе с отчетом о международном поиске.An emulsion composition containing a water component, a non-ionic block copolymer, and an oil in which the copolymer content is at least 10 wt.%. The international application was published along with an international search report.

EA200501368A 2003-02-27 2004-02-20 Stable local and/or mucosal emulsion preparations (embodiments), method for preparing (embodiments) and use thereof (embodiments) EA017434B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003900887A AU2003900887A0 (en) 2003-02-27 2003-02-27 Poloxamer emulsion preparations
PCT/AU2004/000218 WO2004076561A1 (en) 2003-02-27 2004-02-20 Poloxamer emulsion preparations

Publications (2)

Publication Number Publication Date
EA200501368A1 true EA200501368A1 (en) 2006-02-24
EA017434B1 EA017434B1 (en) 2012-12-28

Family

ID=31499933

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501368A EA017434B1 (en) 2003-02-27 2004-02-20 Stable local and/or mucosal emulsion preparations (embodiments), method for preparing (embodiments) and use thereof (embodiments)

Country Status (9)

Country Link
EP (1) EP1597318A4 (en)
JP (1) JP2006519272A (en)
CN (1) CN100591721C (en)
AU (3) AU2003900887A0 (en)
BR (1) BRPI0408056A (en)
CA (1) CA2516863C (en)
EA (1) EA017434B1 (en)
NO (1) NO20054395L (en)
WO (1) WO2004076561A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132087B2 (en) * 2008-04-21 2015-09-15 Otonomy, Inc. Auris formulations for treating otic diseases and conditions
WO2010076730A1 (en) * 2009-01-02 2010-07-08 Donald, Jenny Method for the treatment of an hiv infection
KR101792200B1 (en) * 2010-04-01 2017-10-31 파마네스트 아베 Thermogelling anaesthetic compositions
LT2689774T (en) * 2011-03-21 2019-03-25 Broda Technologies Co., Ltd Reversely thermo-reversible hydrogel compositions
ITMI20131927A1 (en) 2013-11-20 2015-05-21 Cosmo Technologies Ltd EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTIONING AND / OR ENDOSCOPIC SUBMUCOSAL DISSECTION. EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTION AND / OR ENDOSCOPIC SUBMUCOSAL DISSECTION
MX2016012288A (en) * 2014-03-25 2017-01-23 Genentech Inc Methods of preparing a poloxamer for use in cell culture medium.
US10351750B2 (en) * 2017-02-03 2019-07-16 Saudi Arabian Oil Company Drilling fluid compositions with enhanced rheology and methods of using same
KR101852718B1 (en) * 2017-04-04 2018-05-18 주식회사 제네웰 Kit for pain reduction of incision site after surgical operation
SG11202002351SA (en) * 2017-12-21 2020-07-29 Sigma Aldrich Co Llc Poloxamer compositions and methods of making and using same
IT201900018752A1 (en) * 2019-10-14 2021-04-14 Alessandro Tosetti COMPOSITION BASED ON ESSENTIAL OILS FOR DENTAL USE FOR THE TREATMENT OF PERIODONTITIS AND PERIMPLANT MUCOSITE
RU2762506C1 (en) * 2021-01-20 2021-12-21 Общество С Ограниченной Ответственностью «Диамед-Фарма» Agent for applying oral and nasal cavities and method for its use as part of complex therapy of infectious and inflammatory diseases of nasal and oral cavities
CN114455621B (en) * 2022-01-11 2023-10-27 兰州交通大学 Preparation method of needle-shaped calcium carbonate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003429A1 (en) * 1988-09-23 1990-04-05 Cetus Corporation Lipid microemulsions for culture media
JPH0791555B2 (en) * 1989-12-22 1995-10-04 株式会社資生堂 Cleaning composition
CA2185803C (en) * 1994-03-18 2006-07-11 Edward M. Rudnic Emulsified drug delivery systems
ES2094688B1 (en) * 1994-08-08 1997-08-01 Cusi Lab MANOEMULSION OF THE TYPE OF OIL IN WATER, USEFUL AS AN OPHTHALMIC VEHICLE AND PROCEDURE FOR ITS PREPARATION.
SE9601421D0 (en) * 1996-04-12 1996-04-12 Astra Ab New composition
DE19723308A1 (en) * 1997-06-04 1998-12-10 Wolfgang A Prof Dr Wohlrab Microemulsions useful for topical administration of e.g. local anaesthetics
FR2788007B1 (en) * 1999-01-05 2001-02-09 Oreal NANOEMULSION BASED ON BLOCK COPOLYMERS OF ETHYLENE OXIDE AND PROPYLENE OXIDE, AND ITS USES IN THE COSMETIC, DERMATOLOGICAL AND / OR OPHTHALMOLOGICAL FIELDS
AU2799099A (en) * 1999-03-01 2000-09-21 Basf Corporation Cold processed water-in-oil emulsions
CN1149984C (en) * 1999-06-21 2004-05-19 健一制药株式会社 Anesthetic compsn. for intravenous injection comprising propofol
SE0000774D0 (en) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs

Also Published As

Publication number Publication date
AU2004215921A1 (en) 2004-09-10
AU2009202265B2 (en) 2012-02-16
BRPI0408056A (en) 2006-02-14
AU2009202265A1 (en) 2009-07-02
EP1597318A4 (en) 2006-06-14
CA2516863C (en) 2011-12-06
EA017434B1 (en) 2012-12-28
CN1753949A (en) 2006-03-29
WO2004076561A1 (en) 2004-09-10
CN100591721C (en) 2010-02-24
CA2516863A1 (en) 2004-09-10
EP1597318A1 (en) 2005-11-23
NO20054395L (en) 2005-09-22
AU2003900887A0 (en) 2003-03-13
JP2006519272A (en) 2006-08-24

Similar Documents

Publication Publication Date Title
EA200500192A1 (en) REDUCTION OF VISCOSITY OF VISCOELASTIC LIQUIDS BASED ON SURFACE-ACTIVE SUBSTANCES
EA200501368A1 (en) EMULSION COMPOSITION FOR ACTIVE SUBSTANCES (OPTIONS), METHOD OF OBTAINING IT (OPTIONS) AND CONTAINING IT MEANS (OPTIONS)
EA200100693A1 (en) FLUID EMULSIONS CONTAINING WATER AND OIL AND INCLUSION OF GAS BUBBLES
BR0006005A (en) Stable oil composition in glycerinopopically applicable
EA200200858A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING INHIBITORS GLYCOGEN PHOSPHORILASE
BRPI0409499A (en) VOC-free water-in-water microemulsion, consumable, and method for imparting, accentuating, ameliorating or modifying the odorous properties of a composition or article
ID26033A (en) METHOD OF STABILIZATION OF PHARMACEUTICAL COMPOSITION MATERIALS WITH SPECIFIC USE OF ANTIOXIDE
EA200300348A1 (en) SPIROHETEROCYCLIC NITRILS, SUITABLE FOR USE AS REVERSIBLE ACTING INHIBITORS OF CYSTEINE PROTEASIS
PE20011118A1 (en) (+) - 6- [AMINO- (6-CHLORO-PYRIDIN-3-IL) - (3-METHYL-3H-IMIDAZOL-4-IL) -MEthyl] -4- (3-CHLORO-PHENYL) -1- CYCLOPROPYLMETIL-1H-QUINOLEIN-2-ONA AS AN ANTI-CANCER COMPOUND AND A USEFUL METHOD OF SEPARATION OF ENANTHYLOMERS TO SYNTHESIZE SUCH COMPOUND
WO2006007841A3 (en) Heat-induced antigen retrieval methods and compositions therefor
DE60234420D1 (en) Hair treatment agents
NO20024221D0 (en) Mixtures containing alpha-2-adrenergic agonist components
ATE407997T1 (en) LIQUID DETERGENT COMPOSITION AND METHOD FOR USE THEREOF
MY136592A (en) Polymer emulsions resistant to biodeterioration
ATE457161T1 (en) COMPOSITION
ATE399847T1 (en) MULTIPLE EMULSION TYPE CLEANING AGENT
EA200001179A1 (en) METHOD FOR CLEANING WATER, SOIL, SEDIMENTS AND / OR SLUDGE
EA200600753A1 (en) BOTTOM LIQUID, CONTAINING VISCOELASTIC SURFACE-ACTIVE GELS WITH REDUCED SALT CONCENTRATION
AR043401A1 (en) STABLE CONDIMENT WITH CHEESE FLAVOR
EA200401442A1 (en) COMPOSITION CONTAINING JAVAN CITRONELL OIL, AND ITS APPLICATION AS REPELLENT FROM INSECTS
ES2174428T3 (en) Hardened aqueous compositions based on ISOCIANATE WITH LOW CONTENT IN VOLATILE ORGANIC COMPOUNDS.
MXPA03007941A (en) Emulsion phase having improved stability.
DK1412448T3 (en) Method for controlling saturation of a formation around a fire
EA200500532A1 (en) PETROCHEMICAL METHOD FOR TREATMENT AND PREVENTION OF THE FORMATION OF EMULSION OF THE TYPE “OIL IN WATER” AND “WATER IN OIL” IN OIL WELLS AND EARTH EQUIPMENT
DE60218744D1 (en) PARTICULAR COMPOSITION CONTAINING A LIPOPHILIC LIQUID

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU